Organization · Venture Capital
DNA Capital
DNA Capital is a healthcare investment firm based in São Paulo, Brazil, and San Francisco, California. It focuses on multi-stage investments in healthcare companies across Latin America and North America.
Overview
What DNA Capital does
What DNA Capital is
DNA Capital is a healthcare investment firm based in São Paulo, Brazil, and San Francisco, California. It focuses on multi-stage investments in healthcare companies across Latin America and North America.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find DNA Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
DNA Capital as a funder
Investment thesis
DNA Capital focuses exclusively on healthcare investments, partnering with founders and management teams to build leading healthcare businesses across various stages.
Focus narrative
DNA Capital invests exclusively in the healthcare sector, targeting companies at early, growth, and late stages. The firm emphasizes high-quality investments that align with its ethical standards, operating globally with a particular focus on North and South America.
Value beyond capital
DNA Capital adds value to its portfolio companies through its extensive network and operational expertise, leveraging the Bueno family's strategic holdings in healthcare to provide unique insights and access to resources that enhance growth and scalability.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Healthcare · Digital Health · Health Platforms · Health Insurance Tech · Medical Devices · Telemedicine · Clinical Trials · Diagnostics · Pharma Tech · Health Data
- Regions
- North AmericaLatin America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 24
- Recorded notable exits
- Clover Health
Portfolio context
Notable portfolio companies include: Alto Pharmacy: A healthcare service provider. Arterys: A medical imaging company utilizing cloud computation and AI. Beep Saúde: A vaccination service provider operating in Brazil. Clover Health: A health insurance company. Dasa: The largest diagnostic medicine company in Latin America. Galileo: A healthtech startup focused on enhancing the doctor-patient relationship. Memed: An e-prescribing tool aimed at improving patient care. Sanar: A digital healthcare education platform. Viveo: A provider of integrated healthcare services and products.
Common questions
What to know about DNA Capital
Upseed classifies DNA Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.